#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3540217	ADME	Drug level in Sprague-Dawley rat liver microsomes treated with [14C]-rivoglitazone at 20 uM after 4 hrs by radio-HPLC/LC-MS/MS analysis in presence of UDPGA and UDPGA/SAM	Rattus norvegicus	2	ALA3526048	assay format	Scientific Literature
2.	ALA3540218	ADME	Drug level in cynomolgus monkey liver microsomes treated with [14C]-rivoglitazone at 20 uM after 4 hrs by radio-HPLC/LC-MS/MS analysis in presence of UDPGA and UDPGA/SAM	Macaca fascicularis	2	ALA3526048	assay format	Scientific Literature
3.	ALA3540219	ADME	Drug level in human liver microsomes treated with [14C]-rivoglitazone at 20 uM after 4 hrs by radio-HPLC/LC-MS/MS analysis in presence of UDPGA and UDPGA/SAM	Homo sapiens	2	ALA3526048	assay format	Scientific Literature
4.	ALA3540244	ADME	Drug level in monkey plasma treated with [14C]rivoglitazone assessed as ratio of molar basis AUC (0 to t) at 1 mg/kg, po administered via gavage by LC-MS/MS analysis	Macaca mulatta	14	ALA3525983	organism-based format	Scientific Literature
5.	ALA3541357	ADME	Activity of human UGT1A3 expressed in microsomes isolated from baculovirus infected insect cell assessed as enzyme-mediated compound formation treated with [14C]-rivoglitazone at 20 uM after 4 hrs by radio-HPLC/LC-MS/MS analysis in presence of NADPH-generating system/SAM	Homo sapiens	2	ALA3526048	assay format	Scientific Literature
6.	ALA3541358	ADME	Activity of human UGT2B7 expressed in microsomes isolated from baculovirus infected insect cell assessed as enzyme-mediated compound formation treated with [14C]-rivoglitazone at 20 uM after 4 hrs by radio-HPLC/LC-MS/MS analysis in presence of NADPH-generating system/SAM	Homo sapiens	2	ALA3526048	assay format	Scientific Literature
7.	ALA3537605	Physicochemical	Retention time of the compound by LC-MS/MS analysis		21	ALA3525983	small-molecule physicochemical format	Scientific Literature
8.	ALA3537607	ADME	AUC (0 to t) in monkey plasma treated with rivoglitazone at 1 mg/kg, po administered via gavage by LC-MS/MS analysis	Macaca mulatta	15	ALA3525983	organism-based format	Scientific Literature
9.	ALA3528816	ADME	Drug level in rat hepatocytes treated with [14C]-rivoglitazone at 30 uM after 3 hrs by radio-HPLC/LC-MS/MS analysis in presence of UDPGA and UDPGA/SAM	Rattus norvegicus	2	ALA3526048	cell-based format	Scientific Literature
10.	ALA3528817	ADME	Drug level in monkey hepatocytes treated with [14C]-rivoglitazone at 30 uM after 3 hrs by radio-HPLC/LC-MS/MS analysis in presence of UDPGA and UDPGA/SAM	Macaca mulatta	2	ALA3526048	cell-based format	Scientific Literature
11.	ALA3528818	ADME	Drug level in human hepatocytes treated with [14C]-rivoglitazone at 30 uM after 3 hrs by radio-HPLC/LC-MS/MS analysis in presence of UDPGA and UDPGA/SAM	Homo sapiens	2	ALA3526048	cell-based format	Scientific Literature
12.	ALA3530967	Physicochemical	Retention time of the compound by LC-MS/MS analysis		14	ALA3526048	small-molecule physicochemical format	Scientific Literature
13.	ALA3530493	ADME	Drug excretion in monkey urine treated with [14C]rivoglitazone at 1 mg/kg, po administered via gavage measured during 0 to 72 hrs by radio-HPLC analysis	Macaca mulatta	14	ALA3525983	organism-based format	Scientific Literature
14.	ALA3530494	ADME	Drug excretion in monkey feces treated with [14C]rivoglitazone at 1 mg/kg, po administered via gavage measured during 0 to 72 hrs by radio-HPLC analysis	Macaca mulatta	14	ALA3525983	organism-based format	Scientific Literature
15.	ALA3530495	ADME	Drug excretion in monkey urine/feces treated with [14C]rivoglitazone at 1 mg/kg, po administered via gavage measured during 0 to 72 hrs by radio-HPLC analysis	Macaca mulatta	14	ALA3525983	organism-based format	Scientific Literature